featured
Dr. Warren Heymann on Angiosarcomas and Morbid Obesity: An Enormous Problem
Written by
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
- Sturm R, Hattori A. Morbid obesity rates continue to rise rapidly in the US. Int J Obes (Lond). 2013;37(6):889-891.
- Shon W, Ida CM, Boland-Froemming JM, et al. Cutaneous angiosarcoma arising in massive localized lymphedema of the morbidly obese. J Cutan Pathol. 2011;38(7):560-564.
- Salas S, Stock N, Stoeckle E, et al. Chronic lymphedema due to morbid obesity: An exceptional cause of abdominal wall angiosarcoma. Virchows Arch. 2008;453(2):217-219.
- Lim G, Irfan M, Bergfeld WF, Sood A. Abdominal pannus with verrucous nodules, ecchymosis, and ulcerations in the setting of lymphedema. Int J Dermatol. 2017;56(2):e16-e18.
- Harker D, Jennings M, McDonough P, et al. MYC amplification in angiosarcomas arising in the setting of chronic lymphedema of morbid obesity. J Cutan Pathol. 2017;44(1):15-19.
- Chow W, Amaya CN, Rains S, et al. Growth attenuation of cutaneous angiosarcoma with propranol-mediated beta blockade. JAMA Dermatol. 2015;151(11):1226-1229.
- Biswas B, Dabkara D. Bevacizumab in advanced angiosarcoma: What is the reality? J Clin Oncol. 2016;34(7):764.